The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
The specificities of small molecule inhibitors of the TGFß and BMP pathways
Open accessAbstract
Small molecule inhibitors of type 1 receptor serine threonine kinases (ALKs1-7), the mediators of TGFß and BMP signals, have been employed extensively to assess their physiological roles in cells and organisms. While all of these inhibitors have been reported as "selective" inhibitors of specific ALKs, extensive specificity tests against a wide array of protein kinases have not been performed. In this study, we examine the specificities and potencies of the most frequently used small molecule inhibitors of the TGFß pathway (SB-431542, SB-505124, LY-364947 and A-83-01) and the BMP pathway (Dorsomorphin and LDN-193189) against a panel of up to 123 protein kinases covering a broad spectrum of the human kinome. We demonstrate that the inhibitors of the TGFß pathway are relatively more selective than the inhibitors of the BMP pathway. Based on our specificity and potency profile and published data, we recommend SB-505124 as the most suitable molecule for use as an inhibitor of ALKs 4, 5 and 7 and the TGFß pathway. We do not recommend Dorsomorphin, also called Compound C, for use as an inhibitor of the BMP pathway. Although LDN-193189, a Dorsomorphin derivative, is a very potent inhibitor of ALK2/3 and the BMP-pathway, we found that it potently inhibited a number of other protein kinases at concentrations sufficient to inhibit ALK2/3 and its use as a selective BMP-pathway inhibitor has to be considered cautiously. Our observations have highlighted the need for caution when using these small molecule inhibitors to assess the physiological roles of BMP and TGFß pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C.-H., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,696
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Mechanism of activation of the TGF-β receptor
Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., & Massagué, J. (1994) · Nature · doi:10.1038/370341a0 · Cited by 2,337
Chen, D., Zhao, M., & Mundy, G. R. (2004) · Growth Factors · doi:10.1080/08977190412331279890 · Cited by 1,915
Inman, G. J., Nicolás, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., & Hill, C. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.65 · Cited by 1,634
Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism
Yu, P. B., Hong, C. C., Sachidanandan, C., Babitt, J. L., Deng, D. Y., Hoyng, S. A., Lin, H. Y., Bloch, K. D., & Peterson, R. T. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.2007.54 · Cited by 1,034
NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease
Inohara, N., Chamaillard, M., McDonald, C., & Nuñez, G. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133347 · Cited by 991
Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y., Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2626 · Cited by 851
Padua, D., & Massagué, J. (2009) · Cell Research · doi:10.1038/cr.2008.316 · Cited by 809
Massagué, J., & Gomis, R. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.033 · Cited by 721
TGF-ß Signaling in Renal Disease
Bo[Combining Diaeresis]ttinger, E. P., & Bitzer, M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000033611.79556.ae · Cited by 711
DORSAL-VENTRAL PATTERNING AND NEURAL INDUCTION IN XENOPUS EMBRYOS
De Robertis, E. M., & Kuroda, H. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.011403.154124 · Cited by 671
Laping, N. J., Grygielko, E., Mathur, A., Butter, S., Bomberger, J., Tweed, C., Martin, W., Fornwald, J., Lehr, R., Harling, J., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.1.58 · Cited by 635
BMP type I receptor inhibition reduces heterotopic ossification
Yu, P. B., Deng, D. Y., Lai, C. S., Hong, C. C., Cuny, G. D., Bouxsein, M. L., Hong, D. W., McManus, P. M., Katagiri, T., Sachidanandan, C., et al. (2008) · Nature Medicine · doi:10.1038/nm.1888 · Cited by 634
Nguyen, V. H., Schmid, B., Trout, J., Connors, S. A., Ekker, M., & Mullins, M. C. (1998) · Developmental Biology · doi:10.1006/dbio.1998.8927 · Cited by 438
DaCosta Byfield, S., Major, C., Laping, N. J., & Roberts, A. B. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.744 · Cited by 414
Uhl, M., Aulwurm, S., Wischhusen, J., Weiler, M., Ma, J. Y., Almirez, R., Mangadu, R., Liu, Y.-W., Platten, M., Herrlinger, U., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1013 · Cited by 414
Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors
Cuny, G. D., Yu, P. B., Laha, J. K., Xing, X., Liu, J.-F., Lai, C. S., Deng, D. Y., Sachidanandan, C., Bloch, K. D., & Peterson, R. T. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.06.052 · Cited by 343
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., Node, M., & Imamura, T. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00103.x · Cited by 339
Transforming growth factor beta (TGF-β) and inflammation in cancer
Bierie, B., & Moses, H. L. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.008 · Cited by 334
Callahan, J. F., Burgess, J. L., Fornwald, J. A., Gaster, L. M., Harling, J. D., Harrington, F. P., Heer, J., Kwon, C., Lehr, R., Mathur, A., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010493y · Cited by 308
Sawyer, J. S., Anderson, B. D., Beight, D. W., Campbell, R. M., Jones, M. L., Herron, D. K., Lampe, J. W., McCowan, J. R., McMillen, W. T., Mort, N., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205705 · Cited by 236
Hao, J., Daleo, M. A., Murphy, C. K., Yu, P. B., Ho, J. N., Hu, J., Peterson, R. T., Hatzopoulos, A. K., & Hong, C. C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002904 · Cited by 209
Bueno, L., de Alwis, D. P., Pitou, C., Yingling, J., Lahn, M., Glatt, S., & Trocóniz, I. F. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.008 · Cited by 201
The disparate role of BMP in stem cell biology
Varga, A. C., & Wrana, J. L. (2005) · Oncogene · doi:10.1038/sj.onc.1208919 · Cited by 197
Grygielko, E. T., Martin, W. M., Tweed, C., Thornton, P., Harling, J., Brooks, D. P., & Laping, N. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082099 · Cited by 190
Effect of TGF-?/Smad signaling pathway on lung myofibroblast differentiation
GU, L., ZHU, Y.-J., YANG, X., GUO, Z.-J., XU, W.-B., & TIAN, X.-L. (2007) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2007.00468.x · Cited by 184
Dorsomorphin and LDN-193189 inhibit BMP-mediated Smad, p38 and Akt signalling in C2C12 cells
Boergermann, J. H., Kopf, J., Yu, P. B., & Knaus, P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.018 · Cited by 175
de Gouville, A., Boullay, V., Krysa, G., Pilot, J., Brusq, J., Loriolle, F., Gauthier, J., Papworth, S. A., Laroze, A., Gellibert, F., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706172 · Cited by 166
BMP Signaling and Skeletogenesis
Li, X., & Cao, X. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.006 · Cited by 165
Wrighton, K. H., Lin, X., Yu, P. B., & Feng, X. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809223200 · Cited by 137
Applications of small molecule BMP inhibitors in physiology and disease
Hong, C. C., & Yu, P. B. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.021 · Cited by 121
Peng, S.-B., Yan, L., Xia, X., Watkins, S. A., Brooks, H. B., Beight, D. W., Herron, D. K., Jones, M. L., Lampe, J. W., McMillen, W. T., et al. (2005) · Biochemistry · doi:10.1021/bi048851x · Cited by 100
Tumor-Specific Efficacy of Transforming Growth Factor-βRI Inhibition in Eker Rats
Laping, N. J., Everitt, J. I., Frazier, K. S., Burgert, M. E., Portis, M. J., Cadacio, C., Gold, L. I., & Walker, C. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1811 · Cited by 70
The TGFß pathway as a therapeutic target in cancer
Seoane, J. (2008) · Clinical & Translational Oncology · doi:10.1007/s12094-008-0148-2 · Cited by 59
Cannon, J. E., Upton, P., Smith, J. C., & Morrell, N. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00871.x · Cited by 58
ALK7, a Receptor for Nodal, Is Dispensable for Embryogenesis and Left-Right Patterning in the Mouse
Jörnvall, H., Reissmann, E., Andersson, O., Mehrkash, M., & Ibáñez, C. F. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9383-9389.2004 · Cited by 55
Itoh, F., Itoh, S., Carvalho, R. L. C., Adachi, T., Ema, M., Goumans, M., Larsson, J. T., Karlsson, S., Takahashi, S., Mummery, C. L., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2009.37 · Cited by 21
Cited by
Derivation of Human Trophoblast Stem Cells
Okae, H., Toh, H., Sato, T., Hiura, H., Takahashi, S., Shirane, K., Kabayama, Y., Suyama, M., Sasaki, H., & Arima, T. (2018) · Cell Stem Cell · doi:10.1016/j.stem.2017.11.004 · Cited by 903
The promise and peril of chemical probes
Arrowsmith, C. H., Audia, J. E., Austin, C., Baell, J., Bennett, J., Blagg, J., Bountra, C., Brennan, P. E., Brown, P. J., Bunnage, M. E., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1867 · Cited by 839
Molecular mechanism of action of metformin: old or new insights?
Rena, G., Pearson, E. R., & Sakamoto, K. (2013) · Diabetologia · doi:10.1007/s00125-013-2991-0 · Cited by 479
Beyond TGFβ: roles of other TGFβ superfamily members in cancer
Wakefield, L. M., & Hill, C. S. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3500 · Cited by 374
Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase
Hunter, R. W., Hughey, C. C., Lantier, L., Sundelin, E. I., Peggie, M., Zeqiraj, E., Sicheri, F., Jessen, N., Wasserman, D. H., & Sakamoto, K. (2018) · Nature Medicine · doi:10.1038/s41591-018-0159-7 · Cited by 313
Metadata
- Authors
- Vogt, J., Traynor, R., & Sapkota, G. P.
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 23
- Issue
- 11
- Pages
- 1831-1842
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2137218119
- Cited by
- 256
- References
- 42
- FWCI
- 8.46
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.